When a COX-2 inhibitor was added, only the hyporeactivity to serotonin of arteries from CLP-AF group was significantly restored to the level of SHAM group, compared to CLP-HN and CLP-AFA groups (Fig 3C to 3F, S2 Table). The gene discussed is PTGS2; the disease is atrial fibrillation.